Life-science briefing: Friday, April 4, 2008
TODAY’S HEADLINES:
IlluminOss Medical gets $11M for bone-fracture devices (peHUB)
Contract researcher Crown Bioscience takes in funding (release)
IlluminOss Medical gets $11M for bone-fracture devices — East Providence, R.I.-based IlluminOss Medical, a medical-device startup, raised $11 million in a second funding round, peHUB reports. Backers included New Leaf Ventures and Foundation Medical Partners.
The company’s Web site is barely more than a stub that describes IlluminOss as a device company “pioneering new frontiers in orthopedic surgery.” peHUB offers the… Continue Reading
Life sciences briefing: Wednesday, Jan. 16, 2008
TODAY’S HEADLINES:
Drug-screening tool maker IonGate Bio raises €4.6M (release)
Protein-drug maker Molecular Partners gets $5M up front in Centocor deal (PDF release)
ProtaGen takes in €1M for protein biochips (PDF release)
China’s Sundia MediTech, a contract research organization raises second round (release)
Vital-signs implant maker Transoma Medical sets IPO terms, aims for $78M (Edgar)
UMD receives $1M grant for Baltimore biotech incubator (TechJournal South)
Drug-screening tool maker IonGate Bio raises €4.6M — IonGate Biosciences, a Frankfurt, Germany, developer of tools for… Continue Reading
Life sciences briefing: Friday, Jan. 4, 2008
TODAY’S HEADLINES:
Follica pulls out $5.5M for hair loss (release)
WuXi PharmaTech to acquire AppTec Lab for $151 million (release)
U.S. Venture Partners names Laurence Lasky a venture partner (PDF release)
Burrill & Co. promotes several life-science VCs (release)
SV Life Sciences promotes Darren Black to partner (release)
Follica pulls out $5.5M for hair loss – Boston’s Follica, a biotech that aims to reverse hormone-related hair loss, raised $5.5 million in a first funding round. Investors included Interwest Partners and PureTech Ventures.
Follica… Continue Reading
Life sciences briefing: Wednesday, Oct. 17, 2007
Featured companies: Algorithme Pharma, Bacchus Vascular, Botaneco, Cubist Pharmaceuticals, Ikonisys, Healthcare Management Systems, Illumigen Biosciences, Kilmer Capital Partners, Medical Specialties Distributors, Metastatix, Microphage, Orthosoft, Thomas McNerney & Partners, TranS1, TriReme Medical, Wren Medical, Zimmer
UPDATE: Expanded TriReme Medical, Ikonisys and TranS1 items.
UPDATE REDUX: Added MicroPhage item.
Stent-maker TriReme Medical sails off with $15.6M — Pleasanton, Calif.-based TriReme Medical, a device maker developing a new type of artery-opening stent for blood-vessel junctions, raised $15.6 million in a third funding… Continue Reading